Monte Rosa Therapeutics News and Activities

Monte Rosa Therapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Monte Rosa Therapeutics is a company listed under the stock ticker GLUE (US).

View the org chart displaying its 23 main executives

Most searched biographies at Monte Rosa Therapeutics

• Markus Warmuth, Chief Executive Officer and Director
• Eric Hughes, Director
• Chandra Leo, Director

Create your alert
to follow the executive moves at Monte Rosa Therapeutics.

Monte Rosa Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Monte Rosa Therapeutics

• Monte Rosa Therapeutics to Participate in the Jefferies Global Healthcare Conference - Monte Rosa Therapeutics
• Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates - Monte Rosa Therapeutics
• Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs - Monte Rosa Therapeutics
• Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025 - Monte Rosa Therapeutics
• Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference - Monte Rosa Therapeutics
• Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025 - Monte Rosa Therapeutics
• Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Monte Rosa Therapeutics
• Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degraders to Treat HR-positive/HER2-negative Breast Cancer - Monte Rosa Therapeutics
• Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors - Monte Rosa Therapeutics
• Monte Rosa Therapeutics Provides Development Progress Update for Ongoing MRT-2359 Phase 1/2 Study in Patients with MYC-driven Solid Tumors - Monte Rosa Therapeutics
• View more press releases Close

Social media about Monte Rosa Therapeutics

• Monte Rosa Therapeutics on Wikipedia, Google News & Yahoo Finance
• Monte Rosa Therapeutics on LinkedIn, X (Twitter) & YouTube